Doc Type: Patent Application

Multifunctional Cytokines

  • 67 Publications
  • 0 Patent Documents Cite
  • Cites 106 Patent Documents
67 Publications

EP 1944318 A1 cites 67 non-patent publications

  1. ANDERSON ET AL., EUR. J. BIOCHEM., vol. 204, 1992, pages 51 - 56
  2. AUMAILLY ET AL., FEBS LETT., vol. 262, 1990, pages 82
  3. BARBULESCU ET AL., J. IMMUNOL., vol. 160, 1998, pages 3642 - 3647
  4. CALIGIURI ET AL., J. EXP. MED., vol. 171, 1990, pages 1509 - 1526
  5. CAO ET AL., FASEB J., vol. 13, 1999, pages 2195 - 2202
  6. CARROLL; COLLIER, J. BIOL. CHEM., vol. 262, 1987, pages 8707 - 8711
  7. CARUSO ET AL., PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 7024 - 7028
  8. CHROBOCZEK ET AL., VIROL., vol. 186, 1992, pages 280 - 285
  9. CULVER ET AL., SCIENCE, vol. 256, 1992, pages 1550 - 1552
  10. DEKKER ET AL., NATURE, vol. 362, 1993, pages 852
  11. DRANOFF ET AL., PNAS, vol. 90, 1993, pages 3539 - 3543
  12. DREXLER ET AL., LEUK LYMPHOMA, vol. 29, 1998, pages 119 - 128
  13. ENSINGER ET AL., J. VIROL., vol. 10, 1972, pages 328 - 339
  14. ERBS ET AL., CURR. GENET., vol. 31, 1997, pages 1 - 6
  15. GAZIT ET AL., CANCER IMMUNOL. IMMUNOTHER., vol. 35, 1992, pages 135 - 144
  16. GOODING ET AL., CRITICAL REVIEW OF IMMUNOLOGY, vol. 10, 1990, pages 53 - 71
  17. HASHIMOTO ET AL., J IMMUNOL., vol. 163, 1999, pages 583 - 589
  18. HASHIMOTO ET AL., J. IMMUNOL., vol. 1 63, 1999, pages 583 - 589
  19. HERLYN ET AL., J. IMMUNOL. METH., vol. 73, 1984, pages 157 - 167
  20. IOANNIDES ET AL., J. IMMUNOL., vol. 146, 1991, pages 1700 - 1707
  21. KARP ET AL., J. IMMUNOL., vol. 150, 1993, pages 896 - 908
  22. KERN ET AL., GENE, vol. 88, 1990, pages 149 - 157
  23. KIM ET AL., J. BIOL. CHEM., vol. 277, 2002, pages 10998 - 11003
  24. KIM ET AL., PROC. NATL.. ACAD. SCI. USA, vol. 98, 2001, pages 3304 - 3309
  25. KIMURA ET AL., EUR. J. IMMUNOL., vol. 29, 1999, pages 1532 - 1542
  26. KOVESDI ET AL., CURRENT OPINION IN BIOTECHNOLOGY, vol. 8, 1997, pages 583 - 589
  27. KURYUS ET AL., J. BIOL. CHEM., vol. 275, 2000, pages 30653
  28. LUSKY ET AL., J. VIROL, vol. 72, 1998, pages 2022 - 2032
  29. LYNCH ET AL., PROC. NATL. ACAD. SCI. USA, vol. 89, 1992, pages 1138 - 1142
  30. MEAZZA ET AL., INT. J. CANCER, vol. 87, 2000, pages 574
  31. MELERO ET AL., TRENDS IMMUNOL., vol. 22, 2001, pages 113 - 115
  32. MICALLEF ET AL., CANCER IMMUNOL IMMUNOTHER., vol. 43, 1997, pages 361 - 367
  33. MICROB. PATH., vol. 2, 1987, pages 147 - 153
  34. MILLER ET AL., HUM GENE THER., vol. 11, 2000, pages 53 - 65
  35. MILLER ET AL., HUMAN GENE THERAPY, vol. 11, no. 1, 2000, pages 53 - 65
  36. MZOZ ET AL., HUMAN GENE THER., vol. 4, 1993, pages 589 - 595
  37. OKAMURA ET AL., CURR OPIN IMMUNOL., vol. 10, 1998, pages 259 - 264
  38. OKAMURA ET AL., NATURE, vol. 378, 1995, pages 88 - 91
  39. OSAKI ET AL., J IMMUNOL., vol. 160, 1998, pages 1742 - 1749
  40. OSALCI ET AL., GENE THER., vol. 6, 1999, pages 808 - 815
  41. PAWELEC ET AL., CRIT REV ONCOG., vol. 10, 1999, pages 83 - 127
  42. PORGADOR ET AL., J. IMMUNOL., vol. 150, 1993, pages 1458 - 1470
  43. PUTZER ET AL., PROC NATL ACAD SCI U S A., vol. 94, 1997, pages 10889 - 10894
  44. SHANAFELT ET AL., NAT BIOTECH, vol. 18, 2000, pages 1197 - 1202
  45. SHARMA ET AL., CANCER GENE THERAPY, vol. 3, 1996, pages 302 - 313
  46. SLOS ET AL., CANCER GENE THER., vol. 8, 2001, pages 321 - 332
  47. SON ET AL., CANCER RES., vol. 61, 2001, pages 884 - 888
  48. SON Y-I ET AL: "Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, vol. 61, no. 3, 1 February 2001 (2001-02-01), pages 884 - 888, XP002319787, ISSN: 0008-5472
  49. SORSCHER ET AL., GENE THERAPY, vol. 1, 1994, pages 223 - 238
  50. STUNN ET AL., GENES AND DEV., vol. 2, 1988, pages 1582
  51. SUSUKI ET AL., J. LEUKOC. BIOL., vol. 69, 2001, pages 531
  52. SUZUKI ET AL., J. LEUKOC. BIOL, vol. 69, 2001, pages 531 - 537
  53. TANIGUCHI ET AL., NATURE, vol. 302, 1983, pages 305 - 310
  54. TRINCHIERI, J. EXP. MED., vol. 160, 1984, pages 1147 - 1169
  55. UGAI ET AL., CANCER GENE THERAPY, vol. 10, 2003, pages 187 - 192
  56. USHIO ET AL., J. IMMUNOL., vol. 156, 1996, pages 4274 - 4279
  57. VOSE, INT. J. CANCER, vol. 30, 1982, pages 135 - 142
  58. WADA ET AL., NUCLEIC ACIDS RES., vol. 20, 1992, pages 2111 - 2118
  59. WANG ET AL., GENE THERAPY, vol. 8, 2001, pages 542 - 550
  60. WANG Q ET AL: "Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma", GENE THERAPY, MACMILLAN PRESS LTD., BASINGSTOKE, GB, vol. 8, no. 7, 1 April 2001 (2001-04-01), pages 542 - 550, XP002319788, ISSN: 0969-7128
  61. WEI ET AL., HUMAN GENE THER., vol. 5, 1994, pages 969 - 978
  62. WIEDERRECHT ET AL., CELL, vol. 54, 1988, pages 841
  63. WIGGINTON ET AL., JOURNAL OF IMMUNOLOGY, vol. 169, 2002, pages 4467 - 4474
  64. WIGGINTON J M ET AL: "Synergistic engagement of an ineffective endogenous anti-tumor immune response and induction of IFN-gamma and Fas-ligand-dependent tumor eradication by combined administration of IL-18 and IL-2", JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, vol. 169, no. 8, 15 October 2002 (2002-10-15), pages 4467 - 4474, XP002319786, ISSN: 0022-1767
  65. YEH ET AL., FASEB J., vol. 11, 1997, pages 615 - 623
  66. YEH; PERRICAUDET, FASEB, vol. 11, 1997, pages 615 - 623
  67. ZHU ET AL., CANCER RES., vol. 61, 2001, pages 3725 - 3734
0 Patent Documents

0 patent documents cite EP 1944318 A1

106 Patent Documents

EP 1944318 A1 cites 106 patent documents

  1. EP 0083286 A2 (Jul 6, 1983)
    Modified Vaccinia Virus And Methods For Making And Using The Same.
  2. US 4596556 A (Jun 24, 1986)
    Hypodermic Injection Apparatus
  3. EP 0198474 A1 (Oct 22, 1986)
    Hepatitis B Surface Antigen Formed By Recombinant Dna Techniques, Vaccines, Diagnostics, Cell Lines And Methods Of Forming Same.
  4. EP 0206920 A1 (Dec 30, 1986)
    Expression Vector For Gamma Interferon In Cells Of Mammals, Process For Its Use, Product Obtained And Pharmaceutical Composition Containing Gamma Interferon.
  5. WO 1987/006260 A1 (Oct 22, 1987)
    Viral Vector Coding For A Glycoprotein Of The Virus Responsible For A.i.d.s., Vaccine And Antibody
  6. US 4711955 A (Dec 8, 1987)
    Modified Nucleotides And Methods Of Preparing And Using Same
  7. EP 0302175 A2 (Feb 8, 1989)
    Modified Labeled Nucleotides And Polynucleotides And Methods Of Preparing, Utilizing And Detecting Same.
  8. EP 0304578 A1 (Mar 1, 1989)
    Peptide Comprising Hepatitis B Surface Antigen.
  9. EP 0314569 A1 (May 3, 1989)
    Recombinant Fowlpox Virus, Expression Vectors For Heterologous Proteins, And Vaccines For Fowl Derived From This Virus.
  10. US 4873316 A (Oct 10, 1989)
    Isolation Of Exogenous Recombinant Proteins From The Milk Of Transgenic Mammals
  11. WO 1990/001496 A1 (Feb 22, 1990)
    Polypeptides And Dna Encoding Same
  12. WO 1990/010459 A1 (Sep 20, 1990)
    Pharmaceutical Composition Useful In The Prevention Or Treatment Of Papillomavirus-induced Tumours
  13. EP 0402108 A1 (Dec 12, 1990)
    Thermally Stable Cytosine Deaminase.
  14. EP 0414374 A2 (Feb 27, 1991)
    Novel Antigens And Methods For Their Preparation.
  15. EP 0440267 A1 (Aug 7, 1991)
    Panel Plate For Free Access To Cables.
  16. US 5082658 A (Jan 21, 1992)
    Gamma Interferon-interleukin-2 Synergism
  17. WO 1992/004455 A1 (Mar 19, 1992)
    Multidomain Hematopoiesis Stimulators
  18. WO 1992/007000 A1 (Apr 30, 1992)
    Pharmaceutical Composition For The Treatment Or Prevention Of A Malignant Tumor
  19. WO 1992/016636 A1 (Oct 1, 1992)
    Recombinant Virus Vectors Encoding Human Papillomavirus Proteins
  20. US 5180675 A (Jan 19, 1993)
    Recombinant Fowlpox Virus
  21. WO 1993/001281 A1 (Jan 21, 1993)
    Cytosine Deaminase Negative Selection System For Gene Transfer Techniques And Therapies
  22. WO 1993/002184 A1 (Feb 4, 1993)
    Papilloma Virus Vaccine
  23. WO 1993/010152 A1 (May 27, 1993)
    Hybrid Protein Between Cs From Plasmodium And Hbsag
  24. US 5229109 A (Jul 20, 1993)
    Low Toxicity Interleukin-2 Analogues For Use In Immunotherapy
  25. WO 1994/000152 A1 (Jan 6, 1994)
    Papillomavirus Vaccines
  26. WO 1994/010323 A1 (May 11, 1994)
    Virus With Modified Binding Moiety Specific For The Target Cells
  27. WO 1994/012649 A2 (Jun 9, 1994)
    Gene Therapy For Cystic Fibrosis
  28. WO 1994/020137 A1 (Sep 15, 1994)
    Production Of Human Papillomavirus Capsid Protein And Virus-like Particles
  29. WO 1994/028152 A1 (Dec 8, 1994)
    Defective Adenoviruses And Corresponding Complementation Lines
  30. WO 1995/001447 A1 (Jan 12, 1995)
    Retroviral Vector For The Transfer And Expression Of Genes For Therapeutical Purposes In Eucaryotic Cells
  31. WO 1995/011664 A1 (May 4, 1995)
    Method For Preparing A Viral Aerosol
  32. EP 0673257 A1 (Sep 27, 1995)
    Low Toxicity Interleukin-2 Analogues For Use In Immunotherapy.
  33. WO 1995/032299 A1 (Nov 30, 1995)
    An Autonomous Replication System For Mammalian Cells
  34. WO 1996/017070 A1 (Jun 6, 1996)
    Method Of Preparing A Viral Vector By Homologous Intermolecular Recombination
  35. US 5525711 A (Jun 11, 1996)
    Pteridine Nucleotide Analogs As Fluorescent Dna Probes
  36. WO 1996/026284 A1 (Aug 29, 1996)
    Amplifier Sequences Derived From The Desmin Gene, Vectors Comprising Same And Uses Thereof For Producing Proteins
  37. WO 1996/027677 A2 (Sep 12, 1996)
    Method Of Purification Of Recombinant Viral Vectors Containing A Therapeutic Gene
  38. WO 1996/040958 A1 (Dec 19, 1996)
    Nucleic Acid Transporters For Delivery Of Nucleic Acids Into A Cell
  39. WO 1997/004119 A1 (Feb 6, 1997)
    Viral Vectors And Line For Gene Therapy
  40. WO 1997/035974 A1 (Oct 2, 1997)
    Sequences Ahead Of Gene Sm22, Vectors Containing Same, And Therapeutical Uses Thereof, Particularly For Treating Vascular Diseases
  41. US 5698443 A (Dec 16, 1997)
    Tissue Specific Viral Vectors
  42. WO 1998/000524 A1 (Jan 8, 1998)
    Method For Producing Recombinant Adenovirus
  43. WO 1998/010088 A1 (Mar 12, 1998)
    An Inducible Method For Production Of Recombinant Adeno-associated Viruses Utilizing T7 Polymerase
  44. WO 1998/012302 A1 (Mar 26, 1998)
    Weight Control Pathway Genes And Uses Therefor
  45. WO 1998/015575 A1 (Apr 16, 1998)
    Promoter For Smooth Muscle Cell Expression
  46. US 5747323 A (May 5, 1998)
    Retroviral Vectors Comprising A Vl30-derived Psi Region
  47. WO 1998/020117 A1 (May 14, 1998)
    Prostate-specific Kallikrein
  48. WO 1998/022588 A2 (May 28, 1998)
    An Improved Method For The Production And Purification Of Adenoviral Vectors
  49. US 5759776 A (Jun 2, 1998)
    Targets For Breast Cancer Diagnosis And Treatment
  50. WO 1998/026048 A1 (Jun 18, 1998)
    Methods For Purifying Viruses
  51. US 5776683 A (Jul 7, 1998)
    Methods For Identifying Genes Amplified In Cancer Cells
  52. WO 1998/036768 A1 (Aug 27, 1998)
    Use Of Interleukin-15
  53. US 5801029 A (Sep 1, 1998)
    Cytopathic Viruses For Therapy And Prophylaxis Of Neoplasia
  54. US 5814716 A (Sep 29, 1998)
    Cell Lines From A Transgenic Mouse Which Express Biologically Active Ix Factor
  55. WO 1998/053853 A1 (Dec 3, 1998)
    Combined Product Associating A Nucleic Acid With A Substance Breaking Up The Extracellular Matrix For Gene Therapy
  56. US 5846945 A (Dec 8, 1998)
    Cytopathic Viruses For Therapy And Prophylaxis Of Neoplasia
  57. WO 1998/055639 A2 (Dec 10, 1998)
    Recombinant Adenoviral Vectors Comprising A Splicing Sequence
  58. WO 1998/056415 A1 (Dec 17, 1998)
    Purified Saponins As Oral Adjuvants
  59. WO 1998/058542 A1 (Dec 30, 1998)
    A Process Of Delivering A Polynucleotide Via The Vascular System
  60. EP 0890362 A1 (Jan 13, 1999)
    Compositions Useful For Transferring Therapeutically Active Substances Into A Target Cell, And Their Use In Gene Therapy
  61. WO 1999/003885 A1 (Jan 28, 1999)
    Antitumoral Composition Based On Immunogenic Polypeptide With Modified Cell Location
  62. US 5883320 A (Mar 16, 1999)
    Pedal Guitar
  63. WO 1999/025860 A1 (May 27, 1999)
    Vector For Tissue-specific Replication And Gene Expression
  64. WO 1999/027113 A1 (Jun 3, 1999)
    Mouse Telomerase Reverse Transcriptase
  65. WO 1999/027961 A1 (Jun 10, 1999)
    Transdermal Delivery Of Particulate Vaccine Compositions
  66. WO 1999/040188 A2 (Aug 12, 1999)
    Tumor-associated Antigen Derivatives From The Mage Family, And Nucleic Acid Sequences Encoding Them, Used For The Preparation Of Fusion Proteins And Of Compositions For Vaccination
  67. WO 1999/053061 A2 (Oct 21, 1999)
    Tumor Associated Nucleic Acids And Uses Therefor
  68. WO 1999/054481 A1 (Oct 28, 1999)
    Mutant Having Uracil Phosphoribosyl Transferase Activity
  69. WO 1999/056784 A2 (Nov 11, 1999)
    Use Of A Nuclease Inhibitor Or Interleukin-10 (il-10) For The Preparation Of A Therapeutic Composition For Improving Transfection Of A Polynucleotide Into A Cell And Compositions Useful In Gene Therapy
  70. WO 1999/060128 A1 (Nov 25, 1999)
    Il-2 Selective Agonists And Antagonists
  71. US 5993412 A (Nov 30, 1999)
    Injection Apparatus
  72. US 5998205 A (Dec 7, 1999)
    Vectors For Tissue-specific Replication
  73. EP 0974668 A1 (Jan 26, 2000)
    Use Of Adenoviral E4 Reading Frames To Improve Expression Of A Gene Of Interest
  74. WO 2000/004149 A2 (Jan 27, 2000)
    Compositions And Methods For Therapy And Diagnosis Of Prostate Cancer
  75. WO 2000/012741 A2 (Mar 9, 2000)
    Inducible Expression System
  76. US 6040174 A (Mar 21, 2000)
    Defective Adenoviruses And Corresponding Complementation Lines
  77. WO 2000/015820 A1 (Mar 23, 2000)
    Adenovirus Vectors Containing Cell Status-specific Response Elements And Methods Of Use Thereof
  78. EP 0998945 A1 (May 10, 2000)
    Use Of Magnesium (mg2+) For The Enhancement Of Gene Delivery In Gene Therapy
  79. US 6063622 A (May 16, 2000)
    Adenovirus Vectors
  80. EP 1016711 A1 (Jul 5, 2000)
    Process For Inactivating Enveloped Viruses In A Viral Composition Containing Adenoviruses
  81. EP 1016700 A1 (Jul 5, 2000)
    Water-and-oil Repellant Composition Of Aqueous Dispersion Type And Process For Producing The Same
  82. WO 2000/040702 A1 (Jul 13, 2000)
    Method For Separating Viral Particles
  83. US 6093567 A (Jul 25, 2000)
    Gene Therapy For Cystic Fibrosis
  84. WO 2000/046355 A2 (Aug 10, 2000)
    Telomerase Reverse Transcriptase Transcriptional Regulatory Sequences
  85. US 6110735 A (Aug 29, 2000)
    Method For The Preparation Of A Viral Vector By Intermolecular Homologous Recombination
  86. WO 2000/050573 A1 (Aug 31, 2000)
    Method For Obtaining A Purified Viral Preparation
  87. US 6133028 A (Oct 17, 2000)
    Defective Adenoviruses And Corresponding Complementation Lines
  88. WO 2001/010912 A1 (Feb 15, 2001)
    Multiple Cytokine-antibody Complexes
  89. WO 2001/036650 A2 (May 25, 2001)
    An Oncolytic Adenovirus
  90. WO 2001/047563 A1 (Jul 5, 2001)
    Use Of Lithium (li<+>) For The Preparation Of A Composition For Transfection Of A Polynucleotide Into A Cell And Compositions Useful In Gene Therapy
  91. US 6261550 B1 (Jul 17, 2001)
    G-csf Hybrid Molecules And Pharmaceutical Compositions
  92. WO 2001/068896 A1 (Sep 20, 2001)
    Treatment Of Allergies
  93. EP 1146125 A1 (Oct 17, 2001)
    Poxvirus With Targeted Infection Specificity
  94. WO 2001/093898 A1 (Dec 13, 2001)
    Methods Of Treating Viral Diseases With Il-18 And Il-18 Combinations
  95. WO 2002/040665 A2 (May 23, 2002)
    Complementing Cell Lines
  96. US 6399587 B1 (Jun 4, 2002)
    Recombinant Adenoviral Vectors Comprising A Splicing Sequence
  97. WO 2002/053760 A2 (Jul 11, 2002)
    Chimeric Cytolytic Viruses For Cancer Treatment
  98. WO 2002/063044 A2 (Aug 15, 2002)
    Haplotypes Of The Il15 Gene
  99. US 6440422 B1 (Aug 27, 2002)
    Recombinant Mva Virus, And The Use Thereof
  100. WO 2002/096939 A2 (Dec 5, 2002)
    Adenovirus Protein Ix, Its Domains Involved In Capsid Assembly, Transcriptional Activity And Nuclear Reorganization
  101. US 6492169 B1 (Dec 10, 2002)
    Complementing Cell Lines
  102. WO 2002/101049 A2 (Dec 19, 2002)
    Interleukin-18 Mutants, Their Production And Use
  103. WO 2002/102404 A1 (Dec 27, 2002)
    Uses Of Cytokines
  104. WO 2003/035105 A2 (May 1, 2003)
    A Novel Synthetic Chimeric Fusion Transgene With Immuno-therapeutic Uses
  105. EP 1310561 A1 (May 14, 2003)
    Chimeric Promoters For Controlling Expression In Skeletal Muscle Cells
  106. EP 1523563 A2 (Apr 20, 2005)
    Modified Adenoviral Fiber With Ablated To Cellular Receptors

Sign in to the Lens